Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

MYSTERIOUS: Is edwards lifesciences stock underperforming the dow - You Need To See This

With a market cap of $45.6 billion, Edwards Lifesciences Corporation (EW) offers products and technologies for treating advanced cardiovascular diseases internationally. The company’s product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. 

Companies valued at $10 billion or more are generally described as “large-cap stocks”, and Edwards Lifesciences fits this description perfectly. The company specializes in less invasive treatments for patients with heart valve disorders and continues to pioneer technologies that improve patient outcomes and advance cardiovascular care.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.